Dipyridyl

Dipyridyl

SCHEMBL2250385

[Br-].[Br-].[Ni+2].c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Dipyridyl. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.88
LMNA P02545 3/20 0.88
CCR1 P32246 3/20 0.88
CCR5 P51681 3/20 0.88
CCR8 P51685 3/20 0.88
CYP1A2 P05177 1/20 0.88
POLB P06746 1/20 0.88
METAP1 P53582 1/20 0.88
BLM P54132 1/20 0.88
HIF1A Q16665 1/20 0.88
DOHH Q9BU89 1/20 0.88
P4HTM Q9NXG6 1/20 0.88
NPC1 O15118 5/20 0.70
TP53 P04637 4/20 0.70
RAB9A P51151 4/20 0.70
ALOX15 P16050 3/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
L3MBTL1 Q9Y468 3/20 0.70
HTT P42858 2/20 0.70
TDP1 Q9NUW8 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipyridyl SCHEMBL3751791 1.00 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL29768749 1.00 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL196501 1.00 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL29728717 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL230578 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL35210403 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL30635227 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL9644480 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL809479 0.94 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL8687972 0.94 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6073169-A None JP disclosed
EP-1916244-B1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-12-04 EP disclosed
EP-1882694-B1 OLIGOMERS AND POLYMERS OF THIOPHENE COMPOUNDS HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-04-03 EP disclosed
EP-1348716-B1 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL CO (JP) 2011-10-12 EP disclosed
US-8030438-B2 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-04 US disclosed
US-8008425-B2 Thiophene compound having sulfonyl group and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-30 US disclosed
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2010-01-28 US disclosed
US-20090127491-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
EP-1916244-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2008-04-30 EP disclosed
EP-1882694-A1 THIOPHENE COMPOUND HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2008-01-30 EP disclosed
EP-1348716-A1 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-01 EP disclosed
US-20030180596-A1 Aromatic polymer, method for producing the same and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2003-09-25 US disclosed
US-6197923-B1 N-OXIDATED POLYPYRIDINES, POLYPYRIMIDINES, POLYPYRAZINES, POLYPYRIDAZINES, POLYQUINOLINES, POLYQUINOXALINES, POLYQUINAZOLINES, AND POLYNAPHTHRYDINES; SEMICONDUCTORS; HEAT RESISTANCE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2001-03-06 US disclosed
US-5548048-A Process for manufacturing alkyl-substituted poly (2,2'-diyl) bipyridine-5,5'-diyl TOKYO INSTITUTE OF TECHNOLOGY (JP) 1996-08-20 US disclosed
US-5475082-A Use of poly(alkylpyridine-2,5-diyl) TOKYO INSTITUTE OF TECHNOLOGY (JP) 1995-12-12 US disclosed
US-5436316-A Poly(alkylpyridine-2,5-diyl) and preparation thereof TOKYO INSTITUTE OF TECHNOLOGY (JP) 1995-07-25 US disclosed
US-5424381-A Alkyl-substituted poly(2,2'-bipyridine-5,5'-diyl) and use thereof TOKYO INSTITUTE OF TECHNOLOGY (JP) 1995-06-13 US disclosed
US-5367038-A Polyisoquinolinediyls and uses thereof TOKYO INSTITUTE OF TECHNOLOGY (JP) 1994-11-22 US disclosed
JP-H0673169-A POLY@(3754/24)ALKYLPYRIDIN-2,5-DIYL) POLYMER, ITS PRODUCTION AND METHOD FOR UTILIZING THE SAME POLYMER TOKYO INST OF TECHNOL 1994-03-15 JP disclosed
US-5244992-A Poly(iso)quinolinediyls and preparation and use thereof TOKYO INSTITUTE OF TECHNOLOGY (JP) 1993-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same RRP12, NR2E1, TST KDM4E 3208/4885LMNA 4870/4885CCR1 2068/4885
US-20090127491-A1 THIOPHENE COMPOUND HAVING SULFONYL GROUP AND PROCESS FOR PRODUCING THE SAME TST, ABCG2, CBR3 KDM4E 2440/4885LMNA 4827/4885CCR1 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.